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A subpopulation of cancer cells is believed to be responsible for tumor initiation, propagation, and metas-
tasis. In this issue of Cell Stem Cell, Dieter et al. (2011) show that these functions in colon cancer can be
ascribed to distinct tumor-initiating cell populations.Unraveling hierarchies among cell popu-
lations that at a first glance appear homo-
geneous is an ancient passion of stem
cell researchers. An emerging literature
suggests that tumors are hierarchically
organized like normal tissues, with a
small subpopulation of cancer stem cells
(CSCs) at the apex responsible for cancer
initiation and progression. Whether all
tumor-initiating cells, commonly identified
and characterized on the basis of their
marker expression profiles, are equally
capable of driving tumorigenesis and
metastasis formation has been a matter
of considerable debate. In this issue of
Cell Stem Cell, Dieter et al. use genetic
labeling to assess the contribution of
individual cells to tumor formation in
xenografts. They identify three function-
ally distinct subsets within the colon-
tumor-initiating cell compartment (Dieter
et al., 2011), data which provide further
insight into the heterogeneity of CSC
populations.
A hierarchy of malignant cells was first
recognized in leukemia by Bonnet and
Dick (1997). Six years later, phenotypi-
cally distinct populations of tumorigenic
cells were identified in breast and brain
tumors, followed by studies in which
tumorigenic cells were isolated from a
broad range of tumors on the basis of
their expression of often promiscuous
‘‘stemness’’ markers such as CD133 and
CD44, or their ALDH activity (reviewed in
Clevers, 2011). Although these reports
suggested that homogeneous CSC
populations could be enriched from
tumors on the basis of their surface
marker expression, subsequent work re-
vealed an unexpected complexity within
the glioblastoma (GBM) and melanoma
CSC compartments (Chen et al., 2010,
Roesch et al., 2010). Chen et al. found
that PTEN-deficient GBM tumors con-tained a lineage hierarchy of CD133+
and CD133 populations that were both
capable of self-renewal and tumor initia-
tion. Their findings suggest that PTEN
deficiency, more so than CD133 expres-
sion status, could be an important deter-
minant in the tumor initiation status of
GBM CSCs. Roesch et al. showed that
the H3K4 demethylase JARID1B is func-
tionally required for continuous tumor
growth, but that any melanoma cells
can acquire JARID1B expression to re-
gain cancer-initiating capacity. Taken
together, these studies highlight the facts
that tumor initiation and maintenance
are likely to be dynamic processes and
that therapies targeted against functional
properties of CSCs could potentially be
more effective.
In order to track the activity of single
tumor-initiating cell clones, Dieter et al.
isolated tumorigenic cells from colon
cancer specimens, marked themwith len-
tiviral vectors, and sequenced vector
integration sites present in serially trans-
planted tumors. This approach allowed
the authors to first observe the contribu-
tion of multiple tumor-initiating clones to
primary tumors, and to then see which of
these clones gave rise to secondary and
tertiary tumors. Cells that massively
contributed to the generation of primary
tumors but were not present in subse-
quent serial transplants were termed
T-TAC (tumor transient-amplifying cells),
whereas cells that contributed to both
primary and serial tumors were named
LT-TIC (long-term tumor initiating cells).
The vast majority of LT-TIC clones were
able to form metastases, suggesting that
this subpopulation may be responsible
not only for tumor regeneration, but also
for tumor dissemination. A third category
of cells not detectable in primary tumors
but eventually emerging in subsequentCell Stem Celltransplants was referred to as DC-TIC
(delayed contributing tumor initiating
cells). This intriguing cell population may
be present in primary tumors in a quies-
cent state and would later convert to
a proliferative state either spontaneously
or upon stress stimuli. The initial quies-
cence of DC-TIC may also protect them
from chemotherapy, indicating them as
potential culprits for relapse and distant
tumor recurrence.
The study by Dieter et al. indicates that
a composite tumor-initiating cell popula-
tion constitutes the apex of the pyramid
representing the hierarchical organization
of tumors (Figure 1). It is important to
underline that all tumor-initiating cells
should form tumor xenografts that histo-
logically and phenotypically resemble
the patient’s tumor; a hallmark that distin-
guishes them from commonly used cell
lines that generate disorganized and
highly undifferentiated tumors. Notably,
the T-TAC population identified by Dieter
et al. is included in the tumor-initiating
cell category despite its inability to self-
renew. Accordingly, tumor-initiating cells
are a relatively broad category of cells
capable of forming the tumor of origin in
recipient mice irrespective of whether
they form only a primary tumor (as
T-TAC) or serially transplanted tumors (as
LT-TIC and DC-TIC). CSCs would then be
viewed as a subcategory of tumor-initi-
ating cells that is capable of self-renewal,
a property that is operatively defined by
the ability to produce secondary and
tertiary xenografts in serial transplantation
assays. In brain tumors—but not in colon
tumors—CSCs have been additionally
shown to generate a differentiated prog-
eny of tumor cells that pertains to the
mesodermal germinal leaflet (Ricci-Vitiani
et al., 2008), suggesting that multiple
levels of potency may exist in CSCs9, October 7, 2011 ª2011 Elsevier Inc. 289
Figure 1. Hierarchy of Colon Cancer Cells
Colon tumors contain a small population of CSCs capable of self-renewal that are present in primary
tumors (long-term tumor initiating cells, or LT-TICs) or show up only in subsequent transplants (de-
layed-contributing tumor initiating cells, or DC-TICs). Tumor transient-amplifying cells (T-TACs) generate
the majority of cells in primary tumors, whereas the bulk of nontumorigenic cancer cells contribute little to
tumor growth.
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Previewsfrom different tumors. In contrast to CSCs
and tumor-initiating cells, the bulk of
tumor cells consists of cells that are not
tumorigenic and do not substantially
contribute to tumor propagation.
The study from Dieter et al. provides
a quantitative evaluation of stem cells’
clonal contribution to tumor formation
and confirms the existence of clonal
heterogeneity among tumor-initiating
cells in a patient-derived colon cancer
sample. Together, the studies by Dieter
et al. and Chen et al. reinforce each other
in showing that both colon and brain
tumors harbor different types of tumori-290 Cell Stem Cell 9, October 7, 2011 ª2011genic cells. However, it is important to
note that the majority of the conclusions
drawn about the heterogeneity of both
colon and glioblastoma CSCs are based
on data from tumor-derived cells propa-
gated in vitro as tumor spheres, possibly
neglecting other cell subsets present in
the original tumor that do not thrive in
such culture conditions.
A further aspect that would need clarifi-
cation is the proliferative state of CSCs.
While it has been demonstrated that
breast CSCs undergo more frequent
symmetric divisions than corresponding
normal stem cells (Cicalese et al., 2009),Elsevier Inc.the absolute proliferative activity of
CSCs remains to be determined, and
may well vary among tumor types and
even between individual patients with
the same type of cancer. Since normal
colon stem cells have been proposed to
divide at least as frequently as their
progeny of transient-amplifying cells
(Barker et al., 2008), it is not possible to
exclude the presence of self-renewing
cells in an actively proliferating population
such as T-TAC, as also suggested by the
ability of a fraction of T-TAC to produce
metastasis. As the complexity of the
cancer cell pyramid increases, several
enigmas remain unresolved, providing
a cautionary note against oversimplifying
when characterizing CSC subsets.
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